TV

Themelios Ventures

North America, New York, United States, Tuxedo Park

Description

Themelios Venture Partners L.P. specializes in investments in early and expansion capital companies. The fund typically invests in life

Investor Profile

Themelios Ventures has made 5 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (60%)
  • Series B (20%)
  • Series Unknown (20%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Addiction Treatment
  • Medical Device
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Themelios Ventures frequently co-invest with?

Louisiana Ventures
North America, Nevada, United States, Las Vegas
Co-Investments: 2
Louisiana Funds
North America, Louisiana, United States, Baton Rouge
Co-Investments: 3
Research Corporation Technologies
North America, Arizona, United States, Tucson
Co-Investments: 2
Advantage Capital
North America, Louisiana, United States, New Orleans
Co-Investments: 1
Sanofi
Europe, Ile-de-France, France, Paris
Co-Investments: 1
LT
North America, Louisiana, United States, Baton Rouge
Co-Investments: 1

What are some of recent deals done by Themelios Ventures?

Embera NeuroTherapeutics

Sudbury, Massachusetts, United States

Embera NeuroTherapeutics is a development-stage pharmaceutical company developing treatments for smoking cessation and other addictions.

Addiction TreatmentBiotechnologyMedical DeviceTherapeutics
Series AAug 14, 2011
Amount Raised: $4,500,000
Esperance Pharmaceuticals

Houston, Texas, United States

Esperance Pharmaceuticals develops anticancer drugs that kill cancer cells without harming normal cells.

BiotechnologyHealth CarePharmaceutical
Series BJun 1, 2011
Amount Raised: $7,500,000
Esperance Pharmaceuticals

Houston, Texas, United States

Esperance Pharmaceuticals develops anticancer drugs that kill cancer cells without harming normal cells.

BiotechnologyHealth CarePharmaceutical
Series ANov 24, 2008
Amount Raised: $3,200,000
Embera NeuroTherapeutics

Sudbury, Massachusetts, United States

Embera NeuroTherapeutics is a development-stage pharmaceutical company developing treatments for smoking cessation and other addictions.

Addiction TreatmentBiotechnologyMedical DeviceTherapeutics
Series UnknownSep 15, 2008
Amount Raised: $300,000
Esperance Pharmaceuticals

Houston, Texas, United States

Esperance Pharmaceuticals develops anticancer drugs that kill cancer cells without harming normal cells.

BiotechnologyHealth CarePharmaceutical
Series AOct 31, 2006
Amount Raised: $9,000,000